The multifaceted mechanisms of pristimerin in the treatment of tumors state-of-the-art
As a globally complicated disease, malignant tumor has long been posing a threat to human health with increasingly high morbidity and mortality. Notably, existing treatments for tumors like chemotherapy generally carry intolerable toxicity, necessitating novel agents balancing safety and potency. Am...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-10-01
|
| Series: | Biomedicine & Pharmacotherapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222009647 |
| _version_ | 1811210397982654464 |
|---|---|
| author | YingZheng Wang WeiKe Feng XueZhen Wang Xiao Li Yue Mou XiaoYan Wang YaNan Zhang |
| author_facet | YingZheng Wang WeiKe Feng XueZhen Wang Xiao Li Yue Mou XiaoYan Wang YaNan Zhang |
| author_sort | YingZheng Wang |
| collection | DOAJ |
| description | As a globally complicated disease, malignant tumor has long been posing a threat to human health with increasingly high morbidity and mortality. Notably, existing treatments for tumors like chemotherapy generally carry intolerable toxicity, necessitating novel agents balancing safety and potency. Among them, the anti-tumor potency of herbs, featuring few adverse effects and promising efficacy, has attracted much attention recently. Pristimerin, a Quinone formamide triterpenoid compound extracted from Celastraceae and Portulacaceae, carries pronounced anti-tumor activity. It applies to various malignant tumors, including breast cancer, bile duct cancer, gastric cancer, pancreatic cancer, prostate cancer, glioblastoma, colorectal cancer, oral squamous cell carcinoma, cervical cancer, and lung cancer. In state-of-the-art understanding, pristimerin, alone or combined, can inhibit tumor cell proliferation, induce tumor cell apoptosis, inhibit tumor migration and invasion, inhibit angiogenesis, induce tumor cell autophagy, regulate the occurrence of inflammation related tumors, enhance chemosensitivity and regulate tumor microenvironment and immune cells. Despite the abundance of pristimerin-based research, systematic reviews on its anti-tumor mechanism remain needed. This study presented the anti-tumor mechanism of pristimerin by literature review, which might serve as a reference for further research and clinical practice. |
| first_indexed | 2024-04-12T04:53:42Z |
| format | Article |
| id | doaj.art-9581014df2db4597905c62dea762e091 |
| institution | Directory Open Access Journal |
| issn | 0753-3322 |
| language | English |
| last_indexed | 2024-04-12T04:53:42Z |
| publishDate | 2022-10-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Biomedicine & Pharmacotherapy |
| spelling | doaj.art-9581014df2db4597905c62dea762e0912022-12-22T03:47:11ZengElsevierBiomedicine & Pharmacotherapy0753-33222022-10-01154113575The multifaceted mechanisms of pristimerin in the treatment of tumors state-of-the-artYingZheng Wang0WeiKe Feng1XueZhen Wang2Xiao Li3Yue Mou4XiaoYan Wang5YaNan Zhang6College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province 250355, China; Shandong Co-Innovation Center of Classic TCM Fomula, Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province 250355, ChinaCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province 250355, ChinaCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province 250355, China; Shandong Co-Innovation Center of Classic TCM Fomula, Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province 250355, ChinaCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province 250355, ChinaCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province 250355, China; Shandong Co-Innovation Center of Classic TCM Fomula, Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province 250355, ChinaCollege of Acupuncture and Massage, Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province 250355, ChinaCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province 250355, China; Shandong Co-Innovation Center of Classic TCM Fomula, Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province 250355, China; Corresponding author at: College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province 250355, China.As a globally complicated disease, malignant tumor has long been posing a threat to human health with increasingly high morbidity and mortality. Notably, existing treatments for tumors like chemotherapy generally carry intolerable toxicity, necessitating novel agents balancing safety and potency. Among them, the anti-tumor potency of herbs, featuring few adverse effects and promising efficacy, has attracted much attention recently. Pristimerin, a Quinone formamide triterpenoid compound extracted from Celastraceae and Portulacaceae, carries pronounced anti-tumor activity. It applies to various malignant tumors, including breast cancer, bile duct cancer, gastric cancer, pancreatic cancer, prostate cancer, glioblastoma, colorectal cancer, oral squamous cell carcinoma, cervical cancer, and lung cancer. In state-of-the-art understanding, pristimerin, alone or combined, can inhibit tumor cell proliferation, induce tumor cell apoptosis, inhibit tumor migration and invasion, inhibit angiogenesis, induce tumor cell autophagy, regulate the occurrence of inflammation related tumors, enhance chemosensitivity and regulate tumor microenvironment and immune cells. Despite the abundance of pristimerin-based research, systematic reviews on its anti-tumor mechanism remain needed. This study presented the anti-tumor mechanism of pristimerin by literature review, which might serve as a reference for further research and clinical practice.http://www.sciencedirect.com/science/article/pii/S0753332222009647PristimerinTumorAnti-tumor activity |
| spellingShingle | YingZheng Wang WeiKe Feng XueZhen Wang Xiao Li Yue Mou XiaoYan Wang YaNan Zhang The multifaceted mechanisms of pristimerin in the treatment of tumors state-of-the-art Biomedicine & Pharmacotherapy Pristimerin Tumor Anti-tumor activity |
| title | The multifaceted mechanisms of pristimerin in the treatment of tumors state-of-the-art |
| title_full | The multifaceted mechanisms of pristimerin in the treatment of tumors state-of-the-art |
| title_fullStr | The multifaceted mechanisms of pristimerin in the treatment of tumors state-of-the-art |
| title_full_unstemmed | The multifaceted mechanisms of pristimerin in the treatment of tumors state-of-the-art |
| title_short | The multifaceted mechanisms of pristimerin in the treatment of tumors state-of-the-art |
| title_sort | multifaceted mechanisms of pristimerin in the treatment of tumors state of the art |
| topic | Pristimerin Tumor Anti-tumor activity |
| url | http://www.sciencedirect.com/science/article/pii/S0753332222009647 |
| work_keys_str_mv | AT yingzhengwang themultifacetedmechanismsofpristimerininthetreatmentoftumorsstateoftheart AT weikefeng themultifacetedmechanismsofpristimerininthetreatmentoftumorsstateoftheart AT xuezhenwang themultifacetedmechanismsofpristimerininthetreatmentoftumorsstateoftheart AT xiaoli themultifacetedmechanismsofpristimerininthetreatmentoftumorsstateoftheart AT yuemou themultifacetedmechanismsofpristimerininthetreatmentoftumorsstateoftheart AT xiaoyanwang themultifacetedmechanismsofpristimerininthetreatmentoftumorsstateoftheart AT yananzhang themultifacetedmechanismsofpristimerininthetreatmentoftumorsstateoftheart AT yingzhengwang multifacetedmechanismsofpristimerininthetreatmentoftumorsstateoftheart AT weikefeng multifacetedmechanismsofpristimerininthetreatmentoftumorsstateoftheart AT xuezhenwang multifacetedmechanismsofpristimerininthetreatmentoftumorsstateoftheart AT xiaoli multifacetedmechanismsofpristimerininthetreatmentoftumorsstateoftheart AT yuemou multifacetedmechanismsofpristimerininthetreatmentoftumorsstateoftheart AT xiaoyanwang multifacetedmechanismsofpristimerininthetreatmentoftumorsstateoftheart AT yananzhang multifacetedmechanismsofpristimerininthetreatmentoftumorsstateoftheart |